Recombinant antigen EBNA1 for Epstein-barr virus

Ask for quotation or Call me back

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

View more information about Epstein-Barr virus infection.

REFERENCES

RAG0007

WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA
RAG0047 Satisfaction guarantee

WB, DB, Indirect ELISA, positive control in direct ELISA

GENE

BKRF1

DESCRIPTION

Late nuclear antigen

PURITY

>95% in a SDS-PAGE

SHIPPING AND STORAGE CONDITIONS

Proteins will be shipped on dry ice or ice pack. Upon arrival they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles

STABILITY

The protein will remain stable for four years if stored frozen

SPECIFICITY

The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection

IVD

Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals

SATISFACTION GUARANTEE

83% success rate in evaluations of recombinant antigen EBNA1 (RAG0007) for the development of a diagnostic assay
100% success rate in evaluations of recombinant antigen EBNA1 (RAG0047) for the development of a diagnostic assay

EVALUATION

View Details

PROMOTIONAL MATERIAL

Catalogue
Rekom EBV high quality raw material
Success rate of Rekom Biotech best sellers
Recombinant antigen EBNA1 for Epstein-barr virus